ClariVest Asset Management’s Novavax NVAX Stock Holding History

ClariVest Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.12M	Hold	88,741	–	–	0.11%	243
2024 Q2	$1.12M	Buy	+88,741	New	+$893K	0.11%	243
2022 Q2	–	Sell	-34,308	Closed	-$2.53M	–	740
2022 Q1	$2.53M	Buy	34,308 +28,404	+481%	+$2.53M	0.1%	190
2021 Q4	$845K	Sell	5,904 -596	-9%	-$102K	0.03%	352
2021 Q3	$1.35M	Buy	+6,500	New	+$1.43M	0.04%	278
2021 Q2	–	Sell	-12,300	Closed	-$2.23M	–	802
2021 Q1	$2.23M	Sell	12,300 -2,086	-15%	-$416K	0.08%	198
2020 Q4	$1.6M	Sell	14,386 -8,331	-37%	-$885K	0.05%	232
2020 Q3	$2.46M	Buy	22,717 +757	+3%	+$92.2K	0.08%	196
2020 Q2	$1.83M	Buy	+21,960	New	+$840K	0.05%	241
2016 Q1	–	Sell	-7,784	Closed	-$1.31M	–	654
2015 Q4	$1.31M	Buy	7,784 +2,511	+48%	+$386K	0.04%	249
2015 Q3	$746K	Buy	+5,273	New	+$1.18M	0.02%	295

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ClariVest Asset Management's NVAX Position: Q3 2024 in Review

ClariVest Asset Management held its Novavax (NVAX) position steady in Q3 2024 at 88,741 shares worth $1.12M. The position accounts for 0.11% of the portfolio, ranked #243.

ClariVest Asset Management first reported a position in NVAX in Q3 2015 and has held it in 11 quarters since. The position peaked at $2.53M in Q1 2022. 238 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

ClariVest Asset Management held 88,741 shares of Novavax worth $1.12M as of Q3 2024.
ClariVest Asset Management left its Novavax share count unchanged in Q3 2024.
Novavax made up 0.11% of ClariVest Asset Management's portfolio in Q3 2024, its #243 holding.
ClariVest Asset Management first reported a position in Novavax in Q3 2015 and has held it in 11 quarters since.
ClariVest Asset Management's Novavax position peaked at $2.53M in Q1 2022.
238 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.